An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval)

05/06/2024
24/02/2025
EU PAS number:
EUPAS1000000186
Study
Cancelled

ENCePP Code of conduct

No information provided.
Data sources
No information provided.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Yes

Check completeness

Yes

Check stability

Yes

Check logical consistency

Yes
Data characterisation

Data characterisation conducted

Not applicable
Procedures
No information provided.